Hybrid AFib Louisiana • Lake Charles Medical Destination
Break Free from Longstanding Atrial Fibrillation
FDA-approved Hybrid Convergent Procedure for persistent and longstanding AFib — now available on the Gulf Coast in Lake Charles, Louisiana. Avoid the hassle of big academic centers while accessing a two-team, minimally invasive strategy built for complex AFib.
Minimally Invasive • Two-Team Hybrid Strategy • Designed for Persistent & Longstanding AFib
Serving patients locally in Louisiana and across the U.S., Texas–Louisiana Gulf Coast, and international destinations.
Lake Charles resorts and casinos • Concierge hybrid AFib care • Avoid big-city hospital stress while accessing advanced convergent therapy.
Persistent AFib Is Different.
If atrial fibrillation has lasted more than 12 months despite medications, it is classified as longstanding persistent AFib. These patients face a very different reality than early or paroxysmal AFib.
- Catheter ablation success rates decline significantly
- Recurrence rates increase over time
- Structural remodeling and scarring of the left atrium
- Medication dependency often continues
- Stroke risk and heart failure risk can rise
Persistent AFib requires a comprehensive epicardial + endocardial strategy—not just another pass with the catheter inside the heart.
Evidence-Based Reality
- Single catheter ablation success rates can be as low as 20–45% at 1–2 years in longstanding persistent AFib
- Multiple repeat procedures are often required
- Antiarrhythmic medications frequently continue long-term
- Anticoagulation often remains lifelong despite ablation
If you have been told, “We’ve done all we can,” or “There’s nothing else,” hybrid convergent therapy may offer a different path.
The Hybrid Convergent Procedure
Two Teams. One Strategy. Superior Rhythm Control.
Hybrid convergent therapy combines minimally invasive surgical ablation on the outside of the heart with advanced electrophysiology mapping on the inside. The goal: durable sinus rhythm in patients with longstanding AFib.
Step 1 – Surgical Epicardial Ablation
- Minimally invasive VATS or robotic approach
- Posterior left atrial ablation using EPiSense™ system
- Left atrial appendage ligation
- Ligament of Marshall division
- Roof line creation and posterior wall debulking
By addressing the epicardial substrate on the back wall of the left atrium, this step targets areas often missed by endocardial catheter ablation alone.
Step 2 – Electrophysiology Mapping (4–6 Weeks Later)
- Endocardial catheter mapping of left atrium
- Completion of lesion sets and touch-up ablation
- Electrical isolation confirmation of pulmonary veins and posterior wall
- Verification of left atrial appendage exclusion and conduction block
This staged, collaborative approach allows the EP team to fine-tune rhythm control and confirm durability of the surgical lesions.
Why It Works Better
- Targets posterior wall substrate not reliably reached with catheter alone
- Addresses non-pulmonary vein triggers and complex circuits
- Improves rhythm durability in enlarged or remodeled atria
- Treats left atrial appendage as a potential source of AFib and stroke
Clinical trials and multicenter registries show:
- Up to ~65–80% freedom from AFib at 2 years
- Significant reduction in antiarrhythmic medications
- Many patients able to discontinue anticoagulation after evaluation
- Higher rhythm durability versus catheter ablation alone in persistent AFib
Hybrid Convergent Outcomes*
65–80% Freedom from AFib
At ~2 years in select clinical trials and multicenter registries for persistent AFib.
*Individual results vary. Data summarized from CONVERGE and multicenter registry publications; formal discussion of risks and benefits occurs during consultation.
What Patients Can Expect
Our Lake Charles hybrid AFib program is designed around predictable recovery, clear communication, and long-term rhythm success.
Hospital Stay
1–3 Days
Most patients go home within 1–3 days after the surgical portion of the hybrid procedure.
Pain
Minimally Invasive
Most patients report mild to moderate discomfort that improves quickly with our enhanced recovery protocols.
Rhythm at Discharge
80–90% in Sinus
In many hybrid programs, 80–90% of patients leave the hospital in sinus rhythm after the convergent procedure.
Long-Term Goals
- Durable sinus rhythm
- Reduced medication burden
- Lower stroke risk when appropriate
- Improved exercise tolerance and quality of life
Who Is a Candidate?
Hybrid convergent therapy is built for complex, longstanding AFib—including many patients who have been turned down for repeat procedures elsewhere.
We do not turn away complex patients without a complete, individualized evaluation.
- AFib lasting > 12 months (longstanding persistent AFib)
- Failed prior catheter ablation or cardioversions
- Medication-refractory AFib with symptoms or intolerance
- Enlarged left atrium or structural remodeling
- Obesity with AFib; diabetes and metabolic syndrome
- High-risk patients previously declined for repeat ablation
- Patients seeking alternatives to lifelong rhythm drugs and blood thinners
We review prior records, imaging, and rhythm data and coordinate with your local cardiologist or EP when appropriate.
The ABCDE+S Optimization Framework
Because Rhythm Control Alone Is Not Enough.
We optimize the whole patient before and after surgery—focusing on metabolic health, vascular stability, inflammation, and early detection. This is not just a procedure; it is a rhythm + longevity program.
A – A1C
GLP-1 pathway support and metabolic reset to improve insulin sensitivity and reduce AFib-driving inflammation.
B – Blood Pressure
Tight vascular and hemodynamic control to reduce wall stress, stroke risk, and AFib triggers.
C – Cholesterol
Plaque stabilization and lipid strategy to protect coronary circulation and cerebral perfusion.
D – Diet
Anti-inflammatory nutrition and weight management tailored to cardiac and metabolic risk.
E – Exercise
Graduated cardiac conditioning programs aligned with rhythm status and structural findings.
S – Screening
Coronary calcium scoring, lung cancer CT when indicated, age-based cancer screening, and sleep apnea evaluation.
Destination AFib Care – Lake Charles, Louisiana
Access advanced hybrid AFib convergent therapy without the congestion, cost, and chaos of a big-city medical center. Lake Charles offers a unique blend of resort-level comfort and evidence-based care.
Within ~600-mile Radius
- Houston, Dallas, San Antonio
- Baton Rouge, New Orleans
- Mississippi Gulf Coast
- Alabama Gulf Coast
- Florida Panhandle
International patients welcome with dedicated coordination and telehealth pre-screening.
What We Provide
- Concierge coordination and a dedicated AFib travel coordinator
- Pre-operative telehealth evaluations and record review
- Lodging and resort guidance near Lake Charles casinos and waterfront
- Post-op remote rhythm monitoring and telehealth follow-up
- Coordination with your local cardiologist / electrophysiologist
Our team will outline travel timing, length of stay, and follow-up options tailored to your situation.
Director, Gulf Coast Hybrid AFib Center, Lake Charles, Louisiana
About Dr. Daniel L. Beckles, MD, PhD
Double-Boarded Cardiothoracic Surgeon & Minimally Invasive Thoracic Specialist
Dr. Beckles brings more than 30 years of surgical experience to Gulf Coast Hybrid AFib Center, with a career focused on precision surgery, minimally invasive thoracic approaches, and prevention-driven care.
- American Board Certified in General Surgery and Thoracic Surgery
- Fellowship-trained in minimally invasive thoracic surgery
- Leader in hybrid AFib and convergent techniques
- Expertise in VATS and robotic approaches
- Reduced pain, shorter length of stay philosophy
- Integrated metabolic and longevity medicine mindset
Philosophy: Precision surgery. Metabolic optimization. Longevity medicine. Every convergent procedure is part of a larger plan to extend healthspan, not just suppress an arrhythmia.
Frequently Asked Questions
Straightforward answers to the most common questions about hybrid convergent therapy, blood thinners, and recovery expectations.
Is the convergent hybrid procedure FDA approved?
Yes. The convergent procedure platform used in our hybrid AFib program is FDA approved. We follow guideline-based protocols and review all risks and benefits with you before scheduling.
Will I be able to stop blood thinners (anticoagulation)?
Many patients may qualify to discontinue blood thinners after rhythm stabilization and secure management of the left atrial appendage. This decision is individualized based on your stroke risk score (CHA₂DS₂-VASc), imaging, and shared decision-making with your cardiologist.
What if I failed catheter ablation before?
You may actually be an ideal candidate. Hybrid convergent therapy was designed precisely for patients with persistent or longstanding AFib who have not responded to catheter ablation alone.
Is this open-heart surgery?
No. The convergent procedure is performed through small incisions using minimally invasive thoracoscopic or robotic approaches. The heart is not stopped and there is no sternotomy.
How long is recovery?
Most patients are walking the hallway the day after surgery and resume light activity within days. Return to work and heavier activity depends on your baseline health and job type, and is decided collaboratively with your care team.
For Cardiologists & Electrophysiologists
A Collaborative Hybrid AFib Destination Center on the Gulf Coast
We operate as an extension of your practice, not a competitor. Our hybrid program is designed for longstanding persistent AFib, redo ablations, and high-risk patients seeking a durable rhythm strategy.
- Collaborative model with shared care pathways
- Patients returned to the referring cardiologist post-procedure
- Detailed operative, EP mapping, and follow-up reports
- Access to CONVERGE-style protocols and multicenter best practices
- Options for joint teleconferences and case review
Hybrid Data Packet
We provide a concise evidence packet you can review or share with your group.
- CONVERGE trial summary
- Multicenter registry outcomes
- Comparison: catheter vs. hybrid convergent
- Suggested selection criteria & workflow
Request the digital packet or schedule a case review conference.
Data & Clinical Evidence
Hybrid Convergent vs. Catheter Ablation Alone
Our program is built on the CONVERGE trial, multicenter registries, and real-world data showing meaningful improvements in rhythm control for longstanding persistent AFib.
Key Evidence Highlights
- CONVERGE Trial: Hybrid convergent therapy demonstrated superior freedom from atrial arrhythmias vs. endocardial catheter ablation alone in persistent/longstanding persistent AFib.
- Multicenter registries: Report ~65–80% freedom from AFib at ~2 years in carefully selected patients.
- Stroke reduction: Left atrial appendage management plus rhythm control may reduce stroke risk when combined with appropriate anticoagulation strategies.
- AFib recurrence: Lower need for multiple repeat ablations compared with endocardial catheter-only strategies in this population.
Freedom from AFib at ~2 Years*
Illustrative comparison of catheter ablation alone vs. hybrid convergent in persistent / longstanding persistent AFib.
*Representative of published data; not a guarantee of individual outcome. Full trial citations available on request.
Hybrid AFib Consultation Center
Take the Next Step Toward Freedom from AFib
Share your history, prior procedures, and current medications. Our AFib team will review your case and coordinate the next best step—locally, nationally, or internationally.
Location: Lake Charles, Louisiana
Phone: (XXX) XXX-XXXX
Dedicated AFib Coordinator: [email protected]
- Telehealth consultations available for qualifying patients
- Secure upload portal for prior records and rhythm strips
- Coordinated scheduling for out-of-town and international patients
This form is secure and HIPAA-aware. Do not include social security numbers or payment details.
Persistent AFib Is Not a Life Sentence.
There is another option. Hybrid Convergent Therapy • Lake Charles, Louisiana
Gulf Coast Hybrid AFib Center • Minimally Invasive Convergent AFib Procedure • Lake Charles, Louisiana • Serving Louisiana, Texas, and international patients.